Skip to main navigation

Investors
News Releases
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
IR Resources

News Releases

News Releases

Year

November 21, 2022

Harpoon Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference

November 14, 2022

Harpoon Therapeutics Updates Strategic Priorities and Reports Third Quarter 2022 Financial Results

November 3, 2022

Harpoon Therapeutics to Present Interim Results from Phase 1 Clinical Trial of T Cell Engager HPN217 at the 64th ASH Annual Meeting and Exposition

October 4, 2022

Harpoon Therapeutics Appoints Luke Walker, M.D., as Chief Medical Officer

September 19, 2022

Harpoon Therapeutics Appoints Lauren Silvernail to Board of Directors

September 1, 2022

Harpoon Therapeutics to Participate in Three Upcoming Investor Conferences

August 10, 2022

Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 2, 2022

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences

July 6, 2022

Harpoon Therapeutics Expands Leadership Team

May 26, 2022

Harpoon Presents Interim Data from Ongoing Dose Escalation Portion of T Cell Engager HPN328 Clinical Trial at 2022 ASCO Annual Meeting

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Email Alerts

RSS Feeds

Contact IR

Search

© 2023. Harpoon Therapeutics, Inc. All rights reserved.

Search Investor Relations